Results 101 to 110 of about 6,328 (205)

Enhanced Thermodynamic Stability of UO22+ Complex Through Structure Preorganization of N3O2‐Pentadentate Planar Ligand for Uranium Harvesting from Seawater

Advanced Science, Volume 13, Issue 17, 23 March 2026.
Thanks to the appropriate structure preorganization of an N3O2‐pentadentate planar ligand, 2,6‐bis(2‐hydroxyphenylmethylaminomethyl)pyridine (H2saldamp) exhibits the strongest coordination affinity to UO22+ (log βU = 33.60) compared to ligands developed for uranium harvesting from seawater to date, as well as good separability of UO22+ from other metal
Ryuto Nabata, Satoru Tsushima, Koichiro Takao   +2 more
wiley   +1 more source

Synthesis, docking, and preliminary in vitro/in vivo evaluation of MPP-dithiocarbamate-capped silver nanoparticle as dual-imaging agent for 5HT1A

International Journal of Nanomedicine, 2018
Shubhra Chaturvedi,1 Sangeeta Lal,2 Prasenjit Sen,3 Anil K Mishra1 1Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, New Delhi, Delhi, 2Department of Physics, B.S.
Chaturvedi S, Lal S, Sen P, Mishra AK
doaj  

Tracking early cognitive decline in preclinical AD with brain MRI similarity

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Early detection of neuroanatomical changes in preclinical Alzheimer's disease (AD) is critical for timely intervention. However, conventional magnetic resonance imaging (MRI) and fluid biomarkers often lack sensitivity to subtle structural alterations in early disease stages. METHODS To identify early brain alterations, we applied
Jiawei Sun, Blanca Zufiria‐Gerbolés, Massimiliano Passaretti, Giovanni Volpe, Mite Mijalkov, Joana B. Pereira, for the Alzheimer's Disease Neuroimaging Initiative   +6 more
wiley   +1 more source

Integrating real‐world data with gold‐standard longitudinal clinical and genomic data to advance precision medicine for the Alzheimer's Disease Research Center Program and beyond: a proof‐of‐concept data platform

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Integrating real‐world data (RWD) with clinical research datasets creates more complete, context‐rich resources to drive discovery and enable precision medicine in Alzheimer's disease and related dementias. The National Alzheimer's Coordinating Center conducted a proof‐of‐concept (POC) project to link its longitudinal Uniform Data
Sarah Biber, Jessica E. Culhane, Maria G. Prado, Satish Mathew, Yohali Burrola‐Mendez, Imara I. West, Sarah Van Heiden, Jimmy Phuong, Shilpa Allimatti, Liam G. Lane, Krista L. Moulder, Brittany K. Hale, Amanda Kuzma, Li‐San Wang, Sujuan Gao, Albert Lai, Karthik Natarajan, Sophia Wang, John C. Morris, James M. Noble, Sean D. Mooney, Walter Kukull, Andrew J. Saykin, Kari A. Stephens   +23 more
wiley   +1 more source

Tau PET overlap index correlation with neuropathological findings

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION The tau positron emission tomography (PET) overlap index (OI) has shown promise in maximizing signal‐to‐noise for longitudinal tau PET imaging, particularly for early tau pathology, but requires validation against neuropathology.
Seokbeen Lim, Jeyeon Lee, Paul H. Min, Christina M. Moloney, Carly T. Mester, Sujala Ghatamaneni, Matthew L. Senjem, Hugo Botha, David S. Knopman, Stuart J. McCarter, Vijay K. Ramanan, Rodolfo Savica, Julie A. Fields, Mary M. Machulda, Dennis W. Dickson, R. Ross Reichard, Aivi T. Nguyen, Jonathan Graff‐Radford, Christopher G. Schwarz, Jeffrey L. Gunter, Kejal Kantarci, Bradley Boeve, Prashanthi Vemuri, David T. Jones, Clifford R. Jack Jr., Ronald C. Petersen, Melissa E. Murray, Val J. Lowe   +27 more
wiley   +1 more source

Cognitive screening biases in a secondary prevention Alzheimer's disease clinical trial

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Alzheimer's disease (AD) prevention trials have multiple steps to identify cognitively unimpaired individuals with AD biomarker evidence. Cognitive/functional screening tests may be biased in ethnoracial minorities, impacting trial eligibility.
Isha Sai, Joshua D. Grill, Kyan Younes, Joseph R. Winer, Karly A. Cody, Reisa Sperling, Elizabeth C. Mormino, Christina B. Young   +7 more
wiley   +1 more source

Language deficits across PET‐based Braak stages of tau accumulation in Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract INTRODUCTION Language complaints in cognitively unimpaired (CU) individuals may reflect Alzheimer's Disease (AD) pathology and future objective impairments. METHODS 211 participants (138 CU, 45 with mild cognitive impairment (MCI), and 28 with dementia) from the TRIAD cohort underwent 18F‐MK‐6240 tau‐PET and 18F‐AZD‐4694 amyloid‐PET.
Anna Marier, Jaime Fernández Arias, Étienne Aumont, Brandon J. Hall, Arthur C. Macedo, Nesrine Rahmouni, Gleb Bezgin, Paolo Vitali, Pedro Rosa‐Neto, Maxime Montembeault   +9 more
wiley   +1 more source

Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals

Alzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 2, Issue 1, March 2026.
Abstract INTRODUCTION Relationships between Alzheimer's disease neuropathology, residential neighborhood, and cognitive impairment remain incompletely understood. METHODS We examined whether residence within a disadvantaged neighborhood was associated with amyloid positron emission tomography (PET) positivity.
Charles C. Windon, Elena Tsoy, Jennifer Livaudais‐Toman, Torsten B. Neilands, Nynikka R. Palmer, Margo B. Heston, Julene K. Johnson, Lucy Hanna, Constantine Gatsonis, Justin Romanoff, Jon Steingrimsson, Maria C. Carrillo, Peggye Dilworth‐Anderson, Bruce E. Hillner, Barry A. Siegel, Rachel A. Whitmer, Consuelo H. Wilkins, Karen Smith, Ganna Blazhenets, Renaud La Joie, Bruce L. Miller, Katherine L. Possin, Gil D. Rabinovici   +22 more
wiley   +1 more source

Mausolate Complexes of the Alkaline Earth Metals

ChemistryEurope, Volume 4, Issue 3, March 2026.
Reliable chelation of Ra2+ for radionuclide therapy has long been a challenge, and the capacious and rigid mausolate ligand may offer a promising approach. We describe herein mausolate complexes with the chemically similar Ba2+, and other group 2 dications, including the introduction of functionalized derivatives. The rapid uptake of alkaline earth (Ae)
Jack F. Smart, Liam D. N. Krueckl, R. Quinn Schmidt, Leah Gajecki, Lindsey E. K. Frederiksen, Allen G. Oliver, David J. Berg, J. Scott McIndoe   +7 more
wiley   +1 more source

A new chapter for JACMP: vision, article types, and new initiatives

Journal of Applied Clinical Medical Physics, Volume 27, Issue 3, March 2026.
Yi Rong, Ingrid Reiser
wiley   +1 more source